Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public











Title  Creator  Group name  Publishing year 
Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review Charton et al. EquipeMY Nov 27, 2019
Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD Bascoul-Mollevi et al. EquipeMY May 2018
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer Bascoul-Mollevi et al. EquipeMY 10 2017
The human Mullerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4 Kersual et al. EquipeMY 2014
RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis Lapierre et al. EquipeVC May 2014
Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients Anota et al. EquipeMY 2014
Impact of chromosomal instability on colorectal cancer progression and outcome Orsetti et al. EquipeMY 2014
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy Piron et al. EquipeMY May 2014
Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study Anota et al. EquipeMY 2014


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés